- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05937347
Mindfulness and Cognitive Training Programs for Children With ADHD (the NeuroMind Study) (NeuroMind)
April 19, 2024 updated by: Fundació Sant Joan de Déu
Mindfulness and Cognitive Training Programs for Children With Attention Deficit Hyperactivity Disorder (ADHD): A Randomized, Controlled Trial (the NeuroMind Study)
The present project will evaluate through a Randomized Controlled Trial (RCT) with 5-month follow-up, the efficacy (5-month time horizon), adjunctive to TAU, of three 8-week interventions: a) the Mindfulness for Health program (i. e., M4H), b) a Cognitive Training (CT) program through NeuronUp platform and a program combining both (Mindfulness and Cognitive Training program, i. e., UP4H), a, as compared to TAU, in children (7-12 years old) with ADHD.
In order to evaluate stability of clinical changes and to determine the mechanisms of action of the interventions studied, pre-post changes and at 5-months followup after the start of treatment will be evaluated in ADHD symptoms (inattention, hyperactivity, impulsivity), general functioning, clinical global impression, executive functions (verbal fluency, working memory, cognitive flexibility, inhibition), and comorbid symptoms (disruptive behavior, anxiety and depression) along with mindfulness skills.
In the field of personalized treatment in ADHD, the design of the present study will also make it possible to establish whether certain baseline psychosocial and clinical characteristics may be associated with short- and medium-term clinical response to each of the treatments studied.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Introduction: The NeuroMind study is aimed at assessing the efficacy of 3 interventions based on Mindfulness and/or Cognitive Training programs: a Mindfulness and Cognitive Training program (i. e., UP4H), a Mindfulness program (i. e., M4H) and a Cognitive Training program (i. e. CT).
This study will evaluate the short- and mid-time efficacy of these 3 interventions for the first time in children with ADHD.
The objectives of this 5-month RCT, are (i) to examine the efficacy of adding UP4H, M4H or CT to treatment-as-usual (TAU) for children (7-12 years old) with ADHD; (ii) to identify pre-post differences in ADHD symptoms (inattention, hyperactivity, impulsivity), in executive functions (verbal fluency, working memory, cognitive flexibility, inhibition), and in comorbid symptoms (disruptive behavior, anxiety and depression) in the four study arms and (iii) to analyze the role of the mindful attention awareness as a psychological process variable mediator of 5-month clinical outcomes.
Methods and analysis: Participants will be 120 children with ADHD (7-12 years old) recruited at CSMIJ Sant Joan de Déu Terres de Lleida (Lleida, Spain), randomly allocated to one of the four study arms: TAU vs TAU+CT vs TAU+M4H vs TAU+UP4H.
A comprehensive assessment to collect ADHD symptoms (inattention, hyperactivity, impulsivity), executive functions (verbal fluency, working memory, cognitive flexibility, inhibition), comorbid symptoms (disruptive behavior, anxiety and depression), mindful attention awareness, general functioning and clinical global impression will be conducted pre-intervention, post-intervention (8 weeks), and at 5-month follow-up.
Linear mixed-effects model analyses, mediation analysis and sensitivity analyses will be conducted on the basis of intention-to-treat approach and according to whether the patients are completers, or whether they completed the majority of the sessions (75% attendance).
Study Type
Interventional
Enrollment (Estimated)
120
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Anna Huguet, PhD
- Phone Number: +34 973 26 72 22
- Email: anna.huguet@sjd.es
Study Contact Backup
- Name: Tania Badia
- Email: tania.badia@autonoma.cat
Study Locations
-
-
Barcelona
-
Esplugues De Llobregat, Barcelona, Spain, 08950
- Recruiting
- Fundació Privada per a la Recerca i la Docència Sant Joan de Déu (FSJD)
-
Contact:
- Anna Huguet, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Children of both sexes, between 7 and 12 years of age.
- Diagnosis of ADHD according to the DSM-5 criteria by a specialist and confirmed by the Kiddie-Schedule for Affective Disorders and Schizophrenia, Present and Lifetime Version (K-SADS-PL).
- ADHD medication dose is stable in the last 2 months or there is an informed decision on not taking ADHD medication.
- Children and parents have an adequate mastery of the Spanish language.
- Children and parents are available to meet all visits.
- Children's representatives (either parents or legal guardians) must understand the conditions of the study and sign the informed consent.
- Psychiatric comorbidities are allowed except psychosis, bipolar illness, active suicidality, untreated posttraumatic stress disorder or substance use (checked by the structured interview K-SADS-PL) , provided ADHD is the primary diagnosis in the child.
- Children have an IQ ≥ 80 checked by the Kaufman Brief Intelligence Test (K-BIT).
Exclusion Criteria:
- Diagnosis of Autism Spectrum Disorder (ASD) according to the DSM-5 criteria by a specialist or confirmed by the Social Communication Questionnaire (SCQ).
- Children who received psychological or psycho-educational treatment in the last 2 months or whose parents don't agree not to seek it during the study.
- Children have participated in a mindfulness programme in the past or the current year
- Children are participating in another clinical trial.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: TAU + UP4H
UP4H is a face-to-face and virtual non-pharmacological program based on Mindfulness Training and Cognitive Training.
|
Group treatment protocol of 8 weeks (approximately 105 minutes per week, 75 of face-to-face and 30 of virtual intervention).
|
Active Comparator: TAU + M4H
M4H is a face-to-face non-pharmacological program based on Mindfulness Training.
|
Group treatment protocol of 8 weekly 75 minute sessions (face-to-face intervention).
|
Active Comparator: TAU + CT
CT is a virtual non-pharmacological program based on Cognitive Training.
|
Group treatment protocol of 8 weekly 60 minutes sessions (virtual intervention).
|
Active Comparator: Treatment as Usual (TAU)
Treatment as Usual (TAU) consisted of the prescribed drugs adapted to the ADHD symptomatic profile of each child.
|
Standard pharmacological treatment usually provided to children with ADHD.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
ADHD symptoms (inattention, hyperactivity, impulsivity)
Time Frame: Change from baseline values at 5 months
|
Conners' Parent Rating Scale-Revised (CPRS-R) Short form
|
Change from baseline values at 5 months
|
ADHD symptoms (inattention, hyperactivity, impulsivity)
Time Frame: Change from baseline values at 5 months
|
Conners Continuous Performance Test 3rd Edition (CPT-3)
|
Change from baseline values at 5 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Executive functions (verbal fluency, working memory, cognitive flexibility, inhibition)
Time Frame: Change from baseline values at 5 months
|
Neuropsychological Assessment of Executive Functions in Children (ENFEN)
|
Change from baseline values at 5 months
|
Disruptive behavior, anxiety and depression
Time Frame: Change from baseline values at 5 months
|
Child Behavior Checklist (CBCL)
|
Change from baseline values at 5 months
|
Mindful attention awareness
Time Frame: Change from baseline values at 5 months
|
Mindful Attention Awareness Scale Adapted for Children (MAAS-C).
Total scores of the MAAS-C range from 15 to 90, where higher scores mean a better mindful attention awareness.
|
Change from baseline values at 5 months
|
General functioning
Time Frame: Change from baseline values at 5 months
|
Children's Global Assessment Scale (CGAS).
Total scores of the CGAS range from 1 to 100, where higher scores means a better general functioning.
|
Change from baseline values at 5 months
|
Clinical Global Impression
Time Frame: Change from baseline values at 5 months
|
Clinical Global Impression Scale (CGI).
Total scores of the CGI range from 0 to 7, where higher scores means a worse clinical global impression.
|
Change from baseline values at 5 months
|
Anxiety
Time Frame: Change from baseline values at 5 months
|
Screen for Child Anxiety Related Disorders (SCARED)
|
Change from baseline values at 5 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Albert Feliu, PhD, Universitat Autonoma de Barcelona
- Principal Investigator: Anna Huguet, PhD, CSMIJ Sant Joan de Déu Terres de Lleida
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 20, 2023
Primary Completion (Actual)
March 22, 2024
Study Completion (Estimated)
July 26, 2024
Study Registration Dates
First Submitted
May 29, 2023
First Submitted That Met QC Criteria
July 5, 2023
First Posted (Actual)
July 10, 2023
Study Record Updates
Last Update Posted (Actual)
April 22, 2024
Last Update Submitted That Met QC Criteria
April 19, 2024
Last Verified
June 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NeuroMind
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on ADHD
-
The Hong Kong Polytechnic UniversityRecruiting
-
VIZO Specs LtdRecruiting
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)Recruiting
-
Loewenstein HospitalWingate InstituteRecruiting
-
Florida State UniversityRecruiting
-
Florida International UniversityRecruiting
-
Region Örebro CountyRecruiting
-
Johns Hopkins UniversityWithdrawn
-
Tris Pharma, Inc.Premier Research Group plcCompleted
Clinical Trials on TAU + UP4H
-
University of WashingtonUnited States Department of Defense; Military Suicide Research ConsortiumCompletedSuicidal and Self-injurious Behavior | Suicidal Ideation ActiveUnited States
-
Centro Mente Aberta de MindfulnessConselho Nacional de Desenvolvimento Científico e TecnológicoCompleted
-
IRCCS Centro Neurolesi "Bonino-Pulejo"Recruiting
-
Hospital Universitari Vall d'Hebron Research InstituteUniversitat Autonoma de Barcelona; Ministerio de Ciencia e Innovación, SpainNot yet recruiting
-
Virginia Commonwealth UniversityCompletedSubstance Use Disorders | Substance Abuse | Drug Abuse | Drug Addiction | Drug Dependence | Drug Use Disorders | Substance AddictionUnited States
-
Hospital Universitari Vall d'Hebron Research InstituteParc Sanitari Sant Joan de Déu; Universitat Autonoma de BarcelonaCompleted
-
Universidad Complutense de MadridEnrolling by invitationPsychosis | Trauma, PsychologicalSpain
-
University of Wisconsin, MadisonMedical University of South Carolina; National Heart, Lung, and Blood Institute...Completed
-
Norwegian Center for Violence and Traumatic Stress...Norway: Directorate for Health and Social AffairsCompletedPost-Traumatic Stress DisorderNorway
-
Jeremy KoppelNational Institute of Mental Health (NIMH)RecruitingLate Onset Schizophrenia | Delusional Disorder (Late Onset)United States